Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BAT® safely and effectively. See full prescribing information for BAT®. BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)]Sterile Solution for InjectionInitial U.S. Approval: 2013
Medication labelWhy this: Advisory · dailymed-other
BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] is a mixture of immune globulin fragments indicated for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients. The effectiveness of BAT is based on efficacy studies conducted in animal models of botulism.
- generic_name
- botulism antitoxin heptavalent
- product_names
- Botulism Antitoxin Heptavalent
- ndc
- 60492-0075, 60492-0075-1, 60492-0075-4, 60492-0075-2
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en